Literature DB >> 20198457

The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue.

Licia Polimeni, Ludovica Perri, Mirella Saliola, Stefania Basili, Francesco Violi.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20198457     DOI： 10.1007/s11739-010-0352-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  29 in total

1.  Dilated left atrium and pulmonary veins in patients with calcified coronary artery: a potential contributor to the genesis of atrial fibrillation.

Authors:  Nan-Hung Pan; Hsuan-Ming Tsao; Nen-Chung Chang; Chih-Ming Lee; Yi-Jen Chen; Shih-Ann Chen
Journal:  J Cardiovasc Electrophysiol       Date:  2008-09-17

2.  Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Authors:  Kristian Wachtell; Björn Hornestam; Mika Lehto; David J Slotwiner; Eva Gerdts; Michael H Olsen; Peter Aurup; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Jens Rokkedal; Richard B Devereux
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

3.  Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

Authors:  C Morocutti; G Amabile; F Fattapposta; A Nicolosi; S Matteoli; M Trappolini; G Cataldo; G Milanesi; M Lavezzari; F Pamparana; S Coccheri
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

4.  Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.

Authors:  F L Li-Saw-Hee; A D Blann; D Gurney; G Y Lip
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

5.  Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.

Authors: 
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

6.  Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction.

Authors:  Joseph G Akar; Walter Jeske; David J Wilber
Journal:  J Am Coll Cardiol       Date:  2008-05-06       Impact factor: 24.094

Review 7.  Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Alan S Go; Jonathan L Halperin; Warren J Manning
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

8.  Coronary ischemic events after first atrial fibrillation: risk and survival.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; James B Seward; Toshiji Iwasaka; Teresa S M Tsang
Journal:  Am J Med       Date:  2007-04       Impact factor: 4.965

9.  Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.

Authors:  Domenico Ferro; Lorenzo Loffredo; Licia Polimeni; Filippo Fimognari; Paolo Villari; Pasquale Pignatelli; Valentin Fuster; Francesco Violi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-27       Impact factor: 8.311

10.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965
View more
  8 in total

1.  Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score.

Authors:  Daniele Pastori; Alessio Farcomeni; Daniela Poli; Emilia Antonucci; Francesco Angelico; Maria Del Ben; Roberto Cangemi; Gaetano Tanzilli; Gregory Yoke Hong Lip; Pasquale Pignatelli; Francesco Violi
Journal:  Intern Emerg Med       Date:  2015-10-15       Impact factor: 3.397

Review 2.  Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.

Authors:  Francesco Violi; Gregory Y H Lip; Stefania Basili
Journal:  Intern Emerg Med       Date:  2011-06-11       Impact factor: 3.397

Review 3.  Connexin Remodeling Contributes to Atrial Fibrillation.

Authors:  Michelle M Jennings; J Kevin Donahue
Journal:  J Atr Fibrillation       Date:  2013-08-31

4.  Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project.

Authors:  José Miguel Rivera-Caravaca; Vanessa Roldán; Marta Romera; María Asunción Esteve-Pastor; Mariano Valdés; Gregory Y H Lip; Vicente Vicente; Francisco Marín
Journal:  J Gen Intern Med       Date:  2018-03-22       Impact factor: 5.128

5.  Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study.

Authors:  Valeria Raparelli; Marco Proietti; Carmelo Buttà; Paolo Di Giosia; Domenico Sirico; Paolo Gobbi; Salvatore Corrao; Giovanni Davì; Anna Rita Vestri; Francesco Perticone; Gino Roberto Corazza; Francesco Violi; Stefania Basili
Journal:  Intern Emerg Med       Date:  2014-07-03       Impact factor: 3.397

Review 6.  Mechanisms And Management Of Thrombo-Embolism In Atrial Fibrillation.

Authors:  Francesco Violi; Daniele Pastori; Pasquale Pignatelli
Journal:  J Atr Fibrillation       Date:  2014-10-31

7.  Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis.

Authors:  Wenqi He; Yingjie Chu
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

8.  Atrial Fibrillation Increases the Risk of Peripheral Arterial Disease With Relative Complications and Mortality: A Population-Based Cohort Study.

Authors:  Chia-Jung Chang; Yen-Ting Chen; Chiu-Shong Liu; Wen-Yuan Lin; Cheng-Li Lin; Ming-Chia Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.